Bernt Bøgvald Aarli
Position
Associate Professor, Head of the Medical Skills Centre at the Faculty of Medicine. Pulmonologist and senior consultant at the Department of Thoracic Medicine, Haukeland University Hospital.
Affiliation
- bernt.aarli@uib.no
- Visitor address
-
Department of Thoracic Medicine Haukeland University Hospital
5021 BERGEN - Postal address
-
P.O. Box 7804NO-5020 BergenNorway
Bernt Bøgvald Aarli
Position
Associate Professor, Head of the Medical Skills Centre at the Faculty of Medicine. Pulmonologist and senior consultant at the Department of Thoracic Medicine, Haukeland University Hospital.
Affiliation
Research
Expertises
Specialist in pulmonology and internal medicine. Clinical researcher.
Main research areas
My research interests has been divided between obstructive pulmonary diseases, cystic fibrosis, and covid-19.
COPD
My Ph.D. thesis from 2018 explored tidal Expiratory flow limitation in patients with stable COPD detected non-invasively with impulse oscillometry in the Bergen COPD Cohort Study (BergenCOPD). We also presented normal values for within-breath oscillometric indices in elderly. Later projects on COPD has been investigating the use of a digital clinical decision-support system in the management of COPD. Presently we cooperate with Helse i Hardanger with a project investigating if a 3-days comprehensive concentrated interdisciplinary group rehabilitation program with a digital follow-up can give lasting behavioral changes in patients with COPD leading to more physical activity.
Asthma
In my clinical position at Haukeland University Hospital we have created a registry for patients with severe asthma on biologic therapy. We cooperate with the International Severe Asthma Registry. I am the Norwegian delegate in the Nordic Severe Asthma Network (NSAN) and in the steering commettee of the NORDSTAR research project. Severeal publications have come from the registry cooperation, NSAN, the and the NORDSTAR project.
Cystic fibrosis
I have been a co-investigator in the Vertex, VX20-121-103 study on CFTR-modulator therapy which sparked reasearch interest for this patient group in my department. We currently have a projects on nutrition and physiotherapy in patients with cystic fibrosis where we compare the situation before and after the patient was put on CFTR-modulator therapy.
Post covid fatigue
Following the SARS-CoV-2 pandemic, a large number of patients suffer from long COVID with fatigue as one of the most commonly reported symptoms, impacting level of functioning, quality of life and ability to work. We are cooperating with Helse i Hardanger with a project investigating the effect of a 3-days comprehensive concentrated interdisciplinary group rehabilitation program in patients in patients with long COVID fatigue.
Teaching
Publications
Academic article
- Susanne Hansen; Anna von Bülow; Patrik Sandin et al. (2023). Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort. (external link)
- Vibeke Backer; Lars Olaf Cardell; Lauri Lehtimäki et al. (2023). Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions. (external link)
- Breda Cushen; Mariko Siyue Koh; Trung N. Tran et al. (2023). Adult Severe Asthma Registries: A Global and Growing Inventory. (external link)
- Hanna Sandelowsky; Ulla Møller Weinreich; Bernt Bøgvald Aarli et al. (2021). COPD - do the right thing. (external link)
- Tøri Vigeland Lerum; Carin Meltzer; Jezabel Rodriguez Rivero et al. (2023). A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19. (external link)
- Bente Frisk; Marte Jürgensen; Birgitte Espehaug et al. (2023). A safe and effective micro-choice based rehabilitation for patients with long COVID: results from a quasi-experimental study. (external link)
- Gerd Kvale; Bente Frisk; Marte Jürgensen et al. (2021). Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: Protocol for a nonrandomized clinical intervention study. (external link)
- Charlotte Bjørk Ingul; Anne Edvardsen; Turid Follestad et al. (2022). Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19. (external link)
- Christer Janson; Leif Bjermer; Lauri Lehtimäki et al. (2022). Eosinophilic airway diseases: basic science, clinical manifestations and future challenges. (external link)
- Florence Schleich; Désirée Larenas-Linnemann; Alan Altraja et al. (2025). Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR). (external link)
- Douglas J. Conrad; Barbara A. Bailey; Jon Andrew Hardie et al. (2017). Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. (external link)
- Bernt Bøgvald Aarli; Peter M.A. Calverley; Robert L. Jensen et al. (2017). The association of tidal EFL with exercise performance, exacerbations, and death in COPD. (external link)
- Bernt Bøgvald Aarli; Peter M.A. Calverley; Robert L. Jensen et al. (2015). Variability of within-breath reactance in COPD patients and its association with dyspnoea. (external link)
- Torbjørn Nygård; David Wright; Reidun Lisbet Skeide Kjome et al. (2025). Barriers and enablers to medicine-taking behaviours in chronic obstructive pulmonary disease: a qualitative interview study. (external link)
- Anna von Bülow; Susanne Hansen; Patrik Sandin et al. (2025). Use of High-Dose Inhaled Corticosteroids and Risk of Corticosteroid-Related Adverse Events in Asthma Findings From the NORDSTAR Cohort. (external link)
- Rebecca Røsok Reitan; Bernt Bøgvald Aarli; Magnhild Louise Pollestad et al. (2025). Diet habits and body composition in people with cystic fibrosis under elexacaftor/tezacaftor/ivacaftor treatment - A longitudinal, observational study. (external link)
- Wenjia Chen; Trung N. Tran; John Townend et al. (2025). Impact of biologics initiation on oral corticosteroid use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: a pooled analysis of real-world data. (external link)
- Mette Christophersen Tollånes; Geir E. Sjaastad; Bernt Bøgvald Aarli et al. (2020). Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. (external link)
- Varun Kumar Vijayakumar; Tehmina Mustafa; Bjarte Kjell Nore et al. (2021). Role of a Digital Clinical Decision-Support System in General Practitioners' Management of COPD in Norway. (external link)
- Kirk Geale; Hater Darabi; Maria Linh et al. (2020). NORDSTAR: paving the way for a new era in asthma research. (external link)
- Emanuela Zannin; Bernt Bøgvald Aarli; Leonardo Govoni et al. (2020). Effect of stimulating waveform and of data processing on respiratory impedance measurement. (external link)
- Bente Frisk; Kiri Lovise Njøten; Bernt Bøgvald Aarli et al. (2022). A novel concentrated, interdisciplinary group rehabilitation program for patients with chronic obstructive pulmonary disease: Protocol for a nonrandomized clinical intervention study. (external link)
- Kiri Lovise Njøten; Birgitte Espehaug; Liv Heide Magnussen et al. (2023). Relationship between exercise capacity and fatigue, dyspnea, and lung function in non-hospitalized patients with long COVID. (external link)
- Biplob Kumar Mohanty; Tomas Mikal Lind Eagan; Bernt Bøgvald Aarli et al. (2024). Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis. (external link)
- Susanne Hansen; Anna von Bülow; Alexandra Cooper et al. (2025). Mortality in Severe Asthma - results from the NORDSTAR cohort. (external link)
- Mohsen Sadatsafavi; Trung N. Tran; Ghislaine Scelo et al. (2025). Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics. (external link)
- Bernt Bøgvald Aarli; Tomas Mikal Eagan; Ivar Ellingsen et al. (2013). Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. (external link)
- Bernt Bøgvald Aarli (2015). Å være luftstrømsbegrenset i hvile. (external link)
- Birgitte Tholin; Waleed Khalid Ghanima; Gunnar Einvik et al. (2021). Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. (external link)
- Anna von Bülow; Susanne Hansen; Patrik Sandin et al. (2023). Severe asthma trajectories in adults: findings from the NORDSTAR cohort. (external link)
- Tøri Vigeland Lerum; Trond M Aaløkken; Eivind Brønstad et al. (2020). Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19. (external link)
- Gerd Kvale; Eirik Søfteland; Marte Jürgensen et al. (2024). First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study. (external link)
- Knut Stavem; Trond Heir; Toril Dammen et al. (2022). The course and determinants of post-traumatic stress over 12 months after hospitalization for COVID-19. (external link)
Media interview
Conference poster
- Bernt Bøgvald Aarli; Peter MA Calverley; Tomas Mikal Eagan et al. (2014). Flow limitation during resting breathing is associated with reduced exercise capability in COPD.. (external link)
- Bente Frisk; Marte Jürgensen; Birgitte Espehaug et al. (2023). Micro-choice based rehabilitation for patients with post COVID-19 condition – a 3-month follow-up study.. (external link)
- Bente Frisk; Marte Jürgensen; Birgitte Espehaug et al. (2023). Micro-choice based rehabilitation for patients with post COVID-19 condition – a 3-month follow-up study. (external link)
- Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2011). Expiratory flow limitation (EFL) detected non-invasively as a phenotypic characteristic of COPD. (external link)
- Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2012). Longitudinal Variability Of Expiratory Flow Limitation (EFL) In COPD Patients And Healthy Smokers Detected Non-invasively By Impulse Oscillometry. (external link)
- Bernt Bøgvald Aarli; Peter Calverley; Tomas Mikal Eagan et al. (2010). Reference values for resistance and reactance measures from Impuls Oscillometry in healthy elderly. (external link)
- Bernt Bøgvald Aarli; Peter MA Calverley; Xavier Soler et al. (2016). Longitudinal changes in Peak Oxygen Uptake in Chronic Obstructive Pulmonary Disease (COPD) Patients with Dynamic Hyperinflation and/or Tidal Expiratory Flow Limitation. (external link)
- Bernt Bøgvald Aarli; Robert L. Jensen; Tomas Mikal Eagan et al. (2009). Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD. (external link)
- Bernt Bøgvald Aarli; Bjarte Kjell Nore (2016). Therapeutic choices for COPD following the revised GOLD guidelines. (external link)
- Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2014). Mortality In COPD Patients With Increased Intrabreath Reactance. (external link)
- Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2013). Can intra-breath variations of reactance predict dyspnea?. (external link)
- Susanne Hansen; Anna von Bülow; Patrik Sandin et al. (2022). The prevalence of severe asthma, use of oral corticosteroid and management strategies in the Nordic countries: results from the pan-Nordic NORDSTAR cohort. (external link)
- Bernt Bøgvald Aarli; PM Calverley; Tomas Mikal Eagan et al. (2012). Exacebation history in COPD patients with and without expiratory flow limitation (EFL).. (external link)